Real Chemistry buys Spurwing for first APAC healthcare hub
Real Chemistry’s Spurwing deal gives the healthcare communications group a Singapore base, but the real test is local senior counsel at scale.
Read the full articleYou might also wanna read
PR Firm News: Real Chemistry Acquires Spurwing Communications
Real Chemistry acquires Spurwing Communications, which advises pharmaceutical and healthcare organizations—as well as clients across a broad
FDA Scientists Find Insufficient Evidence for Peptides, Undercutting RFK Jr.'s Push for Expanded Access
RFK Jr. recently added peptide-friendly members to a key panel
medpagetoday.com·9d ago
STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more
Novartis is pushing deeper into antibody-drug conjugate development, paying $1.1 billion upfront to buy Myricx Bio
Novartis to pay $1.1B upfront for UK biotech Myricx to expand the pharma's ADC pipeline
Novartis is pushing deeper into antibody-drug conjugate development, paying $1.1 billion upfront to buy Myricx Bio for a pipeline based on a
Spotify
HHS Secretary Robert F. Kennedy Jr. talked about peptides on his podcast recently. We took a look at the science to find out — is there evid
open.spotify.com·29d agoChemistry Ventures is raising $500M for its second fund
Chemistry Ventures, the VC firm launched by Bessemer, Index Ventures and Andreessen Horowitz alums, is raising $500M for its second fund.
Comments
Sign in to join the conversation.
No comments yet. Be the first.